Kolenda, C.; Medina, M.; Bonhomme, M.; Laumay, F.; Roussel-Gaillard, T.; Martins-Simoes, P.; Tristan, A.; Pirot, F.; Ferry, T.; Laurent, F.;
et al. Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages. Pharmaceutics 2022, 14, 1885.
https://doi.org/10.3390/pharmaceutics14091885
AMA Style
Kolenda C, Medina M, Bonhomme M, Laumay F, Roussel-Gaillard T, Martins-Simoes P, Tristan A, Pirot F, Ferry T, Laurent F,
et al. Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages. Pharmaceutics. 2022; 14(9):1885.
https://doi.org/10.3390/pharmaceutics14091885
Chicago/Turabian Style
Kolenda, Camille, Mathieu Medina, Mélanie Bonhomme, Floriane Laumay, Tiphaine Roussel-Gaillard, Patricia Martins-Simoes, Anne Tristan, Fabrice Pirot, Tristan Ferry, Frédéric Laurent,
and et al. 2022. "Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages" Pharmaceutics 14, no. 9: 1885.
https://doi.org/10.3390/pharmaceutics14091885
APA Style
Kolenda, C., Medina, M., Bonhomme, M., Laumay, F., Roussel-Gaillard, T., Martins-Simoes, P., Tristan, A., Pirot, F., Ferry, T., Laurent, F., & PHAGEinLYON Study Group.
(2022). Phage Therapy against Staphylococcus aureus: Selection and Optimization of Production Protocols of Novel Broad-Spectrum Silviavirus Phages. Pharmaceutics, 14(9), 1885.
https://doi.org/10.3390/pharmaceutics14091885
